Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Marjolein van der Eijk"'
Autor:
Bart W Faber, Stephan Hellwig, Sophie Houard, Nicolas Havelange, Jürgen Drossard, Hubert Mertens, Alexander Croon, Robin Kastilan, Richard Byrne, Nicole van der Werff, Marjolein van der Eijk, Alan W Thomas, Clemens H M Kocken, Edmond J Remarque
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0164053 (2016)
Plasmodium falciparum apical membrane antigen 1 (PfAMA1) is a leading asexual blood stage vaccine candidate for malaria. In preparation for clinical trials, three Diversity Covering (DiCo) PfAMA1 ectodomain proteins, designed to overcome the intrinsi
Externí odkaz:
https://doaj.org/article/46cb131ada9e43298252bc652224aff9
Autor:
Brigitte Vulliez-Le Normand, Bart W Faber, Frederick A Saul, Marjolein van der Eijk, Alan W Thomas, Balbir Singh, Clemens H M Kocken, Graham A Bentley
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0123567 (2015)
The malaria parasite Plasmodium knowlesi, previously associated only with infection of macaques, is now known to infect humans as well and has become a significant public health problem in Southeast Asia. This species should therefore be targeted in
Externí odkaz:
https://doaj.org/article/990ee2b45f2b45609f5d3921acc936b2
Autor:
Ran Zhang, Marjolein van der Eijk, Lennart Hammarström, Imre Kacskovics, Yaofeng Zhao, Nanda de Groot, Zhihui Zhao, Ning Li
Publikováno v:
Animal Biotechnology. 20:242-246
In this study, we evaluated haplotypes of the bovine FCGRT (encoding the FcRn heavy chain) and their relationship to the IgG concentration in bovine colostrum. Four single nucleotide polymorphism (SNP), classified into five haplotypes, were identifie
Autor:
Clemens H. M. Kocken, Brigitte Vulliez-Le Normand, Frederick Saul, Bart W. Faber, Balbir Singh, Graham A. Bentley, Marjolein van der Eijk, Alan W. Thomas
Publikováno v:
PLoS ONE
PLoS ONE, Public Library of Science, 2015, 10 (4), pp.e0123567. ⟨10.1371/journal.pone.0123567⟩
PLoS ONE, 2015, 10 (4), pp.e0123567. ⟨10.1371/journal.pone.0123567⟩
'PloS One ', vol: 10, pages: e0123567-1-e0123567-16 (2015)
PLoS ONE, Vol 10, Iss 4, p e0123567 (2015)
PLoS ONE, Public Library of Science, 2015, 10 (4), pp.e0123567. ⟨10.1371/journal.pone.0123567⟩
PLoS ONE, 2015, 10 (4), pp.e0123567. ⟨10.1371/journal.pone.0123567⟩
'PloS One ', vol: 10, pages: e0123567-1-e0123567-16 (2015)
PLoS ONE, Vol 10, Iss 4, p e0123567 (2015)
International audience; The malaria parasite Plasmodium knowlesi, previously associated only with infection of macaques, is now known to infect humans as well and has become a significant public health problem in Southeast Asia. This species should t
Autor:
Alexander Croon, Clemens H. M. Kocken, Nicolas Havelange, Jürgen Drossard, Sophie Houard, Bart W. Faber, Robin Kastilan, Nicole van der Werff, Alan W. Thomas, Hubert Mertens, Marjolein van der Eijk, Richard W. Byrne, Edmond J. Remarque, Stephan Hellwig
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 10, p e0164053 (2016)
PLoS ONE, Vol 11, Iss 10, p e0164053 (2016)
Plasmodium falciparum apical membrane antigen 1 (PfAMA1) is a leading asexual blood stage vaccine candidate for malaria. In preparation for clinical trials, three Diversity Covering (DiCo) PfAMA1 ectodomain proteins, designed to overcome the intrinsi
Autor:
Vanessa Riasat, Clemens H. M. Kocken, David R. Cavanagh, Vanessa Walraven, Alan W. Thomas, Nicole van der Werff, Bart W. Faber, Anthony A. Holder, Edmond J. Remarque, Roberto Rodriguez Garcia, Sumera Younis, Marjolein van der Eijk
Publikováno v:
Infection and immunity. 81(5)
To overcome polymorphism in the malaria vaccine candidate Plasmodium falciparum apical membrane antigen 1 (PfAMA1), fusion protein chimeras comprised of three diversity-covering (DiCo) PfAMA1 molecules (D1, D2, and D3) and two allelic variants of the
Autor:
Marjolein van der Eijk, Kwadwo A. Kusi, Bart W. Faber, Edmond J. Remarque, Clemens H. M. Kocken, Daniel Dodoo, Samuel Bosomprah
Publikováno v:
BMC Infectious Diseases, Vol 12, Iss 1, p 32 (2012)
BMC Infectious Diseases
BMC Infectious Diseases
Background Establishing antibody correlates of protection against malaria in human field studies and clinical trials requires, amongst others, an accurate estimation of antibody levels. For polymorphic antigens such as apical membrane antigen 1 (AMA1
Autor:
Marjolein van der Eijk, Clemens H. M. Kocken, Edmond J. Remarque, Kwadwo A. Kusi, Bart W. Faber, Alan W. Thomas
Publikováno v:
Malaria Journal, Vol 10, Iss 1, p 40 (2011)
Malaria Journal
Malaria Journal
Background Antibodies to key Plasmodium falciparum surface antigens have been shown to be important effectors that mediate clinical immunity to malaria. The cross-strain fraction of anti-malarial antibodies may however be required to achieve strain-t